Celon Pharma S.A. (WSE:CLN)
19.96
+0.16 (0.81%)
Sep 25, 2026, 11:10 AM CET
Celon Pharma Market Cap
Celon Pharma has a market cap or net worth of 1.07 billion as of September 24, 2026. Its market cap has decreased by -9.17% in one year.
Market Cap
1.07B
Enterprise Value
1.16B
Revenue
257.64M
Ranking
n/a
PE Ratio
9.70
Stock Price
19.96
ChartMarket Cap Chart
Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.07B, an increase of 6.36%. That is a compound annual growth rate of 0.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.07B | -2.70% |
| Dec 30, 2025 | 1.10B | -23.06% |
| Dec 30, 2024 | 1.42B | 80.47% |
| Dec 29, 2023 | 789.33M | 10.32% |
| Dec 30, 2022 | 715.51M | -57.68% |
| Dec 30, 2021 | 1.69B | -7.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.57B |
| NEUCA | 3.10B |
| Synektik Spólka Akcyjna | 2.99B |
| Voxel | 1.53B |
| Medinice | 637.55M |
| Syn2bio | 593.58M |
| Centrum Medyczne ENEL-MED | 571.26M |
| Mercator Medical | 523.69M |